Evaluation of Mutations Related to Streptomycin Resistance in Mycobacterium tuberculosis Clinical Isolates
- 8 October 2022
- journal article
- research article
- Published by Springer Nature in Current Microbiology
- Vol. 79 (11) , 1-7
Abstract
Drug resistance to streptomycin in the clinical isolates of Mycobacterium tuberculosis (MTB) needs special consideration. It can mostly be caused by mutations in four genes with the names rpsL, rrs, gidB, and whiB7. The main objective of this study was the evaluation of the type and frequency of mutations in these mentioned genes using the PCR-sequencing method. This study was performed on 15 streptomycin-resistant and five streptomycin-sensitive isolates. Among resistant isolates, 11 samples contained mutations in codon 43 of the rpsL gene, which caused the lysine to be converted to arginine. Additionally, all of the isolates had mutations in the gidB. Missense mutations in codons 92 and 20 of this gene result in the amino acids Glutamic acid or Arginine being changed to Aspartic acid or Proline, respectively. No mutations in the rrs or whiB7 were found in any of the samples. Simultaneous mutations of rpsL and gidB were found in 10 isolates, the majority of which were Beijing strain. The results showed that the mutations of rpsL and gidB genes are mostly responsible for the streptomycin resistance in the evaluated MTB isolates. Furthermore, the discovery of dual mutations in Beijing strains highlights the strain's considerable potential for developing Tuberculosis drug resistance.Keywords
Funding Information
- Golestan University of Medical Sciences (IR.GOUMS.111209)
This publication has 27 references indexed in Scilit:
- Identification of mutations conferring streptomycin resistance in multidrug-resistant tuberculosis of ChinaDiagnostic Microbiology and Infectious Disease, 2015
- Screening for Streptomycin Resistance-Conferring Mutations in Mycobacterium tuberculosis Clinical Isolates from PolandPLOS ONE, 2014
- Risk factors and drug-resistance patterns among pulmonary tuberculosis patients in northern Karnataka region, IndiaNigerian Medical Journal, 2014
- Analysis of Mutations in Streptomycin-Resistant Strains Reveals a Simple and Reliable Genetic Marker for Identification of the Mycobacterium tuberculosis Beijing GenotypeJournal of Clinical Microbiology, 2013
- Aminoglycoside Cross-Resistance in Mycobacterium tuberculosis Due to Mutations in the 5′ Untranslated Region of whiB7Antimicrobial Agents and Chemotherapy, 2013
- Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of BarcelonaJournal of Antimicrobial Chemotherapy, 2010
- Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from SingaporeClinical Microbiology and Infection, 2010
- Loss of a conserved 7‐methylguanosine modification in 16S rRNA confers low‐level streptomycin resistance in bacteriaMolecular Microbiology, 2007
- Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing ofMycobacterium tuberculosisJournal of Clinical Microbiology, 2006
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBNew England Journal of Medicine, 2006